01
Peptides, without the jargon
What peptides are made from, how they act as biological signals, and why different peptides can produce very different effects.
Peptide Academy
Peptides can influence some of the most interesting signalling systems in the body, from appetite and metabolism to recovery, collagen, growth-hormone signalling, sexual function, cognition and cellular energy. Peptide Academy starts with the big picture, then teaches you how to actually use the information.
Already know the basics?
Jump straight to the tool or reference you need. If you are using a pen, read the pen instructions before using click calculations because devices are not interchangeable.
Important before using a peptide pen
Pen concentration, click scale and mechanism can differ between devices. Never carry a click count from one pen to another. Confirm the exact device and click scale first, then use the calculator only to convert inputs you already know.
Read the pen guideYour Academy progress
Level 01 · Foundations
Build the mental model first: what peptides are, why they matter, how the field developed, the major categories, evidence status and where the science is going.
0% complete
Level 01 · Foundations
Build the mental model first: what peptides are, why they matter, how the field developed, the major categories, evidence status and where the science is going.
01
What peptides are made from, how they act as biological signals, and why different peptides can produce very different effects.
02
The big picture: why peptide signalling is useful, where peptide medicines already work, and the major areas researchers are exploring.
03
From secretin and insulin to synthetic peptides, recombinant production and the modern GLP-1 era.
04
A beginner map of the major peptide categories and why a category is an orientation tool, not a promise of a specific effect.
05
Understand the difference between established medicines, clinical research, early human evidence and preclinical research before comparing claims.
06
Longer-lasting molecules, oral delivery, better targeting, combination biology and why delivery technology is changing what peptide drugs can become.
Level 02 · Peptide Knowledge
Learn how peptide families differ, how to compare compounds intelligently, apply the evidence-first framework to real peptides, compare families and evaluate claims without getting pulled around by hype.
0% complete
Level 02 · Peptide Knowledge
Learn how peptide families differ, how to compare compounds intelligently, apply the evidence-first framework to real peptides, compare families and evaluate claims without getting pulled around by hype.
Part 1 · Learn the framework
Learn families, comparison logic, blends and the repeatable deep-dive method before applying it to individual compounds.
07
Group peptides by the biology they act on so GLP-1 drugs, GHRH analogues, melanocortins, copper peptides and mitochondrial peptides stop looking like one category.
08
Compare target, evidence, route, formulation and outcome instead of asking which peptide is simply ‘better’.
09
Why combining compounds changes the evidence question, makes attribution harder and should not be treated as simple addition.
10
Use one repeatable framework to understand a peptide from mechanism and evidence through formulation, outcomes, uncertainty and the questions that still need answering.
Part 2 · Evidence-first case studies
Six deliberately different case studies show how the same evidence-first method changes when the evidence is strong, mixed, early, formulation-specific or combination-based.
11
See how the evidence-first framework works when a peptide has large randomized human trials, approved products and outcome data across multiple indications.
12
Learn how to separate topical human evidence, formulation effects, mechanistic biology and injectable uncertainty without flattening them into one claim.
13
Use BPC-157 to understand how a broad preclinical literature, a small number of human observations and strong online interest can coexist without proving clinical efficacy.
14
Use tesamorelin to learn why an approved peptide can have strong human evidence while still having a deliberately narrow indication and product-specific context.
15
Explore one of the most exciting metabolic peptide research programmes while separating peer-reviewed Phase 2 evidence, positive Phase 3 results and the remaining regulatory steps.
16
Learn why CJC-1295 DAC, CJC no DAC and ipamorelin must be separated, and why evidence for two components does not validate a popular combination protocol.
Part 3 · Compare & synthesize
Finish the level by comparing peptide families and learning how to evaluate claims without letting mechanism, hype or one exciting result outrun the evidence.
17
Compare signalling families by target, biological system, evidence, endpoints and delivery instead of treating every peptide aimed at the same goal as equivalent.
18
Quickly separate mechanism, animal data, human outcomes, effect size, uncertainty and marketing language so an exciting claim stays interesting without becoming stronger than the evidence.
Level 03 · Practical & Safety
Devices, units, calculators, reconstitution, storage, protocols, tracking and sourcing. Practical information comes after the concepts that make it understandable.
0% complete
Level 03 · Practical & Safety
Devices, units, calculators, reconstitution, storage, protocols, tracking and sourcing. Practical information comes after the concepts that make it understandable.
19
Understand what changes between a pen and a vial, then work through device identification before touching concentration or click math.
20
The small set of conversions that prevents most beginner calculation mistakes.
21
A practical walkthrough showing exactly where each vial and pen calculator input comes from and how to read the result.
22
Understand what reconstitution changes, how dilution affects concentration, and how to work from the vial in front of you.
23
Powder vs reconstituted storage, practical handling concepts, supplies, travel and sharps basics.
24
Separate amount, frequency, timing, cycle length, escalation and the practical assumptions behind a protocol.
25
Learn the difference between starting amount, escalation, maintenance, frequency, cycle length and total exposure.
26
Set a baseline, choose useful measurements, track changes consistently and recognise common versus concerning effects.
27
Interrogate identity, purity, quantity, microbiological testing, real COAs, batch traceability, manufacturing origin, handling and vendor transparency.
Level 04 · Deep Research & Science
Go beyond summaries and learn how to read papers, interpret endpoints and uncertainty, understand bias and pharmacology, and evaluate the wider evidence base rather than one exciting result.
0% complete
Level 04 · Deep Research & Science
Go beyond summaries and learn how to read papers, interpret endpoints and uncertainty, understand bias and pharmacology, and evaluate the wider evidence base rather than one exciting result.
28
Use a structured research workflow before going deeper into paper reading, effect estimates, bias, pharmacology and evidence synthesis.
29
Move through abstract, methods, results, tables and limitations without letting the conclusion paragraph do all the thinking for you.
30
Understand endpoints, absolute and relative effects, confidence intervals and why statistical significance is not the same thing as importance.
31
Learn how selection, confounding, blinding, randomization and control groups change what a study can credibly claim.
32
Separate biomarkers and intermediate endpoints from outcomes that directly matter to how people feel, function or survive.
33
Understand concentration over time, biological response, half-life, exposure and why similar-looking peptides can require very different interpretation.
34
Learn why a response curve is not always linear and why converting an animal amount by body weight does not create a validated human protocol.
35
Learn what evidence synthesis can add, how heterogeneity matters, and why a meta-analysis is only as trustworthy as the studies and methods inside it.
36
Evaluate sponsorship, selective publication, preprints, corrections, retractions and other signals that determine how much confidence a paper deserves.
Peptide families & goals
General knowledge is only the first layer. These are the major areas that connect the foundations to individual peptide profiles, comparisons and current research.
Weight & Metabolism
GLP-1, GIP, glucagon, appetite, metabolism and body-composition research.
Explore peptide profilesRecovery & Repair
BPC-157, TB-500, Wolverine and connective-tissue / recovery research.
Explore peptide profilesGrowth Hormone & Body Composition
Ipamorelin, CJC, tesamorelin and GH-axis concepts.
Explore peptide profilesEnergy & Longevity
MOTS-c, SS-31, NAD+ and mitochondrial / cellular-energy research.
Explore peptide profiles